Drug-eluting stents are recommended as a possible treatment for people with coronary artery disease only if:

  • the artery to be treated is less than 3 mm in diameter or the affected section of the artery is longer than 15 mm, and
  • the additional cost of the drug-eluting stents over bare-metal stents is £300 or less.

This guidance replaces sections 1.2-1.4 of NICE technology appraisal guidance 71 (2003).

Additional funding information for this guidance can be found on the Department of Health website.

  • National Institute for Health and Care Excellence (NICE) accreditation logo